These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18053085)

  • 1. The glucocorticoid receptor signalling in breast cancer.
    Moutsatsou P; Papavassiliou AG
    J Cell Mol Med; 2008; 12(1):145-63. PubMed ID: 18053085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor signaling and prostate cancer.
    Kassi E; Moutsatsou P
    Cancer Lett; 2011 Mar; 302(1):1-10. PubMed ID: 21078539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor and breast cancer.
    Vilasco M; Communal L; Mourra N; Courtin A; Forgez P; Gompel A
    Breast Cancer Res Treat; 2011 Nov; 130(1):1-10. PubMed ID: 21818591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway.
    Kim SL; Choi HS; Kim JH; Lee DS
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression.
    He L; Yuan L; Sun Y; Wang P; Zhang H; Feng X; Wang Z; Zhang W; Yang C; Zeng YA; Zhao Y; Chen C; Zhang L
    Cancer Res; 2019 Sep; 79(17):4399-4411. PubMed ID: 31289134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible roles for glucocorticoid signalling in breast cancer.
    McNamara KM; Kannai A; Sasano H
    Mol Cell Endocrinol; 2018 May; 466():38-50. PubMed ID: 28687451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between NFkB and glucocorticoid signaling: a potential target of breast cancer therapy.
    Ling J; Kumar R
    Cancer Lett; 2012 Sep; 322(2):119-26. PubMed ID: 22433713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells.
    Zhou L; Zhong Y; Yang FH; Li ZB; Zhou J; Liu XH; Li M; Hu F
    BMB Rep; 2016 Mar; 49(3):167-72. PubMed ID: 26424557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids promote breast cancer metastasis.
    Obradović MMS; Hamelin B; Manevski N; Couto JP; Sethi A; Coissieux MM; Münst S; Okamoto R; Kohler H; Schmidt A; Bentires-Alj M
    Nature; 2019 Mar; 567(7749):540-544. PubMed ID: 30867597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptor-IRS-1 axis controls EMT and the metastasis of breast cancers.
    Shi W; Wang D; Yuan X; Liu Y; Guo X; Li J; Song J
    J Mol Cell Biol; 2019 Dec; 11(12):1042-1055. PubMed ID: 30726932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor.
    Han L; Wang B; Wang R; Gong S; Chen G; Xu W
    Stem Cell Res Ther; 2019 Dec; 10(1):377. PubMed ID: 31805987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
    Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
    Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor signaling in the eye.
    Sulaiman RS; Kadmiel M; Cidlowski JA
    Steroids; 2018 May; 133():60-66. PubMed ID: 29129720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New dimension of glucocorticoids in cancer treatment.
    Lin KT; Wang LH
    Steroids; 2016 Jul; 111():84-88. PubMed ID: 26930575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
    Noureddine LM; Trédan O; Hussein N; Badran B; Le Romancer M; Poulard C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
    Wallace AD; Cidlowski JA
    J Biol Chem; 2001 Nov; 276(46):42714-21. PubMed ID: 11555652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines.
    Ewing TM; Murphy LJ; Ng ML; Pang GY; Lee CS; Watts CK; Sutherland RL
    Int J Cancer; 1989 Oct; 44(4):744-52. PubMed ID: 2793247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.
    Leehy KA; Regan Anderson TM; Daniel AR; Lange CA; Ostrander JH
    J Mol Endocrinol; 2016 Apr; 56(3):R99-R114. PubMed ID: 26831511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
    Ferrand N; Stragier E; Redeuilh G; Sabbah M
    Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells.
    Leo JC; Guo C; Woon CT; Aw SE; Lin VC
    Endocrinology; 2004 Mar; 145(3):1314-21. PubMed ID: 14617569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.